Dr. Fen Jiang MD

Recommended Articles

• Overcoming Lymphoma: A South Philly Student's Story

  In April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...

• How Retaining One Normal BRCA Gene Influences Survival in Ovarian Cancer Patients

  The National Cancer Institute reports that around 250,000 people will be diagnosed with breast cancer this year, and about 22,000 with ovarian cancer. While the survival rate among patients with breast cancer is significantly higher compared to ovarian cancer – the NCI reports about 40,000 of the...

• New Cell Therapy Shows Promise as Potential Lymphoma Fighter

  Diffuse Large B Cell Lymphoma (DLBCL) is a particular form of lymphoma (cancer involving the lymph nodes) that has begun to affect more and more patients across the world. Unlike most cancers, there have been a large amount of success stories of treatment options that help patients beat the disease....

• Why Clinical Trials Are Essential for Advancement in Ovarian Cancer Treatment

  Women who have ovarian cancer need to understand that the best hope for improved screening methods and more effective treatments lies within their participation in clinical trials. Research is the cornerstone of improved medical advances, but work needs to be done at every level and for every stage...

• What Are the Causes and Symptoms of Stomach Cancer?

  Stomach cancer, also known as gastric cancer, refers to the cancer that develops in the lining of the stomach. Of the different types of cancer, cancer that develops in the glandular tissue, called adenocarcinoma, is the most common. Few stomach cancers develop in the connective tissue, like muscles...

• $5.8 Million Grant Given to Develop New Immunotherapy for Ovarian Cancer

  Ovarian cancer cells can be extremely tricky to get rid of, which makes treatment often expensive and prolonged. Researchers at the University of California San Diego recently received a 5.8-million-dollar grant from the state to develop a new form of immunotherapy for ovarian cancer.The StudyThe...